« Previous article
Latest Updates on CO...

30th June 2020  Content supplied by: various sources as indicated

Latest Updates on COVID-19 Testing - Kits, Products, Services, Instrumentation - 30 June 2020


With the resurgence of the virus resulting from foreign travel and the flu season ever approaching, the development and validation of COVD-19 test kits keep going. With so many kits being developed, we've tried our best to cherry-pick the most important product updates for you here.

Don't forget to check out the latest kits, standards, and controls at our Coronavirus (SARS-CoV-2): Test Kits to Detect the Causative Agent of COVID-19 Test Method Guide

 

Free Samples! WESAIL 5 Min CE-Marked IgM/IgG Antibody COVID-19 Test Kit

Free Samples! WESAIL 5 Min CE-Marked IgM/IgG Antibody COVID-19 Test Kit

WESAIL Biotech launches IgM/IgG Antibody COVID-19 Test Kit with 99% specificity and ≥90% sensitivity. It is used for the qualitative detection of IgM/IgG antibody in human whole blood/serum/plasma samples and indicates recent and previous infections in one single test.
Find Out More

 

New Test Uses Surrogate Virus to Check Effectiveness of Cleaning for COVID-19

New Test Uses Surrogate Virus to Check Effectiveness of Cleaning for COVID-19

Campden BRI has developed a new test using a SARS-CoV-2 surrogate virus to assess the effectiveness of disinfection operations. Campden BRI can test sanitisers and other cleaning products in its UK laboratories, and can also test and advise on the effectiveness of cleaning practices.
Find Out More

 

Warning Letters Sent to Risky COVID-19 Antibody Test Kit Suppliers

Warning Letters Sent to Risky COVID-19 Antibody Test Kit Suppliers

The US FDA has sent out warning letters to several companies who are illegally marketing COVID-19 serology kits as FDA approved and for also using the FDA logo on kits. FDA are encouraging health care professionals and consumers to report any concerns on quality to the FDA's MedWatch.
Find Out More

 

Early Validation Data on COVID-19 Antigen Test Shows Promise Say Developers

Early Validation Data on COVID-19 Antigen Test Shows Promise Say Developers

Avacta and Cytiva, who are developing a point-of-care COVID-19 antigen detection test, are pleased with early performance data and claim the test can detect the virus' spike protein within the clinical range found in the saliva of COVID-19 patients. 
Find Out More

 

Enhanced Performance and High-Throughput Screening up to 384 Samples Simultaneously

Enhanced Performance and High-Throughput Screening up to 384 Samples Simultaneously

The GenePro SARS-CoV-2 RT-PCR test, developed by Gencurix (South Korea), has received FDA-EUA. The kit can work on a variety of PCR instruments and has been designed to work on 384-well plates, quadrupling standard runs. 
Find Out More

 

First Commercial Lab USA Offering Testing for SARS-CoV-2 in Wastewater

First Commercial Lab USA Offering Testing for SARS-CoV-2 in Wastewater

Monitoring water samples collected from wastewater treatment facilities for coronavirus RNA, can provide data on the prevalance of COVID-19 within a community, track the spread of the virus and alert communities to a rise in RNA levels before clinical diagnosis.
Find Out More


    

Tags:

Date Published: 30th June 2020


View full company details




rapidmicrobiology.com

Address:

Cork

Ireland

Tel: +[353] 23 88 31884

Email Supplier

View full company details


Related news from rapidmicrobiology.com